Hedge Fund - Schonfeld Strategic Advisors
Bio-Rad Laboratories Inc. (BIO BIOB)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $1,078,970 | 0.01% | 4,430 | $ |
| 2 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $ |
| 3 | 2024 - Q3 (2024-09-30) | $468,412 | 0% | 1,400 | $ |
| 4 | 2024 - Q2 (2024-06-30) | $369,789 | 0% | 1,354 | $ |
| 5 | 2024 - Q1 (2024-03-31) | $0 | 0% | 0 | $ |
| 6 | 2023 - Q4 (2023-12-31) | $484,335 | 0% | 1,500 | $ |
| 7 | 2023 - Q3 (2023-09-30) | $366,335 | 0% | 1,022 | $ |
| 8 | 2023 - Q2 (2023-06-30) | $19,338,152 | 0.16% | 51,008 | $ |
| 9 | 2023 - Q1 (2023-03-31) | $104,335,345 | 0.99% | 217,810 | $ |
| 10 | 2022 - Q4 (2022-12-31) | $76,293,285 | 0.63% | 181,439 | $ |
| 11 | 2022 - Q3 (2022-09-30) | $73,008,000 | 0.61% | 175,022 | $ |
| 12 | 2022 - Q2 (2022-06-30) | $152,375,000 | 1.47% | 307,828 | $ |
| 13 | 2022 - Q1 (2022-03-31) | $92,909,000 | 0.83% | 164,958 | $ |
| 14 | 2021 - Q4 (2021-12-31) | $128,744,000 | 1.16% | 170,394 | $ |
| 15 | 2021 - Q3 (2021-09-30) | $138,124,000 | 1.42% | 185,166 | $ |
| 16 | 2021 - Q2 (2021-06-30) | $74,942,000 | 0.79% | 116,317 | $ |
| 17 | 2021 - Q1 (2021-03-31) | $70,400,000 | 0.85% | 123,257 | $ |
| 18 | 2020 - Q4 (2020-12-31) | $55,641,000 | 0.74% | 95,448 | $ |
| 19 | 2020 - Q3 (2020-09-30) | $18,505,000 | 0.35% | 35,898 | $ |
| 20 | 2020 - Q2 (2020-06-30) | $16,916,000 | 0.43% | 37,467 | $ |
| 21 | 2020 - Q1 (2020-03-31) | $10,386,000 | 0.65% | 29,626 | $ |
| 22 | 2019 - Q4 (2019-12-31) | $38,061,000 | 0.92% | 102,861 | $ |
| 23 | 2019 - Q2 (2019-06-30) | $18,626,000 | 0.65% | 59,587 | $ |
| 24 | 2019 - Q1 (2019-03-31) | $5,258,000 | 0.18% | 17,200 | $ |
| 25 | 2018 - Q4 (2018-12-31) | $2,044,000 | 0.07% | 8,798 | $ |
| 26 | 2018 - Q3 (2018-09-30) | $1,877,000 | 0.08% | 6,000 | $ |
| 27 | 2018 - Q2 (2018-06-30) | $10,824,000 | 0.58% | 37,512 | $ |
| 28 | 2018 - Q1 (2018-03-31) | $381,000 | 0.02% | 1,523 | $ |
| 29 | 2017 - Q4 (2017-12-31) | $1,161,000 | 0.09% | 4,864 | $ |
| 30 | 2017 - Q1 (2017-03-31) | $294,000 | 0.02% | 1,472 | $ |
| 31 | 2016 - Q4 (2016-12-31) | $584,000 | 0.07% | 3,202 | $ |
| 32 | 2016 - Q1 (2016-03-31) | $309,000 | 0.12% | 2,259 | $ |
The displayed share prices are average quarterly stock market prices.